MENU
MGNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MacroGenics (MGNX) Ownership - Who owns MacroGenics?
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
339
Web
https://www.macrogenics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
76.97M
P/E Ratio
N/A
Total Cash
200.36M
Projected Growth
N/A
Total Debt
34.1M
Revenue
139.77M
Risk (Beta)
1.43
Dividend Yield
N/A
Total Cash/Share
3.18
Total Debt/Equity
N/A
Revenue/Share
2.37 USD as % of share price
Fundamentals
MGNX
Capitalization
77M
P/E Ratio
N/A
Risk (Beta)
1.43
Dividend Yield
N/A
Total Cash
200M
Total Cash/Share
3.18
Total Debt
34.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.37%
Revenue
140M
ROE
N/A
Book Value
120M
P/B Ratio
0.66
Cash Flow
N/A
Earnings
-1.57
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
627K
Current Ratio
3.75
Current Revenue Per Employee
326572.28
Dividends Per Share - Security
N/A
EBITDA
-89.09M
Float
N/A
Float - Current
N/A
Gross Income Margin
98.31
Revenue To Assets
-32.30
Shares Held By Institutions
268M
Shares Outstanding - Current
63.1M
Total Liabilities
144M
Total Volume MTD
N/A
Value
-1
Gain YTD
-62.462
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the discovery and development of monoclonal antibody-based therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
339
Web
https://www.macrogenics.com